Leo Grady, CEO of Jona, is pioneering the use of artificial intelligence (AI) to analyze the gut microbiome, offering new insights into health and disease. His previous work in AI at Paige, where he focused on pathology, laid the foundation for his current mission: to unlock the potential of the microbiome in diagnosing and managing various health conditions. The new version of Jona’s product, launching soon, revolutionizes how microbiome data is presented to both patients and healthcare providers. By breaking down the data into five key health areas—GI, metabolic, brain, skin, and physical performance—Jona’s AI delivers actionable insights with easy-to-understand red, green, and yellow status indicators.
This new release enhances the user experience by simplifying the complex data of the microbiome, moving beyond just identifying organisms to understanding their functional impact on a person’s health. Doctors can now quickly assess the overall health status of their patients, identify problem areas, and drill down into specific issues like how the microbiome is linked to depression or metabolic health. This not only improves patient care but also empowers individuals to take control of their health through lifestyle changes, supplements, and medications, providing a holistic view of wellness.
Looking to the future, Leo envisions Jona evolving into a key tool for preventative health. By leveraging AI to continually analyze the microbiome, Jona aims to provide early diagnostics for conditions such as Parkinson’s disease, fatty liver disease, and colorectal cancer. Ultimately, Jona could become part of routine checkups, offering personalized health insights to prevent illness, optimize performance, and guide targeted therapeutic interventions. This vision positions Jona as a groundbreaking platform in the future of healthcare.
Takeaways
- AI-Driven Microbiome Insights: Jona’s new product leverages AI to simplify complex microbiome data, offering actionable insights that can guide healthcare providers in making faster, more informed decisions for their patients.
- Holistic Health Impact: The new release focuses on the functional role of the microbiome in five key health areas—GI, metabolic, brain, skin, and physical performance—allowing both patients and doctors to understand how microbiome imbalances affect overall wellness and targeted areas of health.
- Future of Preventative Health: Jona is positioning itself to become a critical tool for early diagnostics and personalized health management, with the potential to integrate into routine checkups, enabling proactive health tracking and prevention of chronic diseases.
This article was originally published on the SonarMD website and is republished here with permission.
About the Show
An inside look at value-based care in GI
Listen in as Dr. K brings patients, providers and payers together to reimagine GI care in America. He and his guests will discuss emerging trends, research, care and payment models, technologies, regulatory pressures, policies and more. It’s time for a gut check on how GI can help meet the quadruple aim in healthcare: an improved patient experience, better health of the overall population, lower costs and happier providers.
Show rebroadcasts at 8:00am, 4:00pm and 12:00 am ET every weekday.
About Dr. K
Dr. Lawrence Kosinski (@lrkosinski) is the Founder and Chief Medical Officer of SonarMD – a care coordination and drug optimization solution for gut health. After spending 30+ years of his career as a leading clinician and researcher in gastroenterology, Dr. K is now 100% dedicated to bringing patients, providers and payers together to advance value-based care. Dr. K is routinely tapped to present at leading GI and payer conferences, including DDW, GI Outlook, AHIP and others. He has published numerous research projects and previously served on the governing board of the American Gastroenterological Association.
Read Dr. K’s full bio and learn more about the SonarMD team.